RPL17 and rheumatoid arthritis: In conclusion, we conducted a meta-analysis of all the eligible studies related to the rs36084323 (PD-1.1 G/A), rs11568821 (PD-1.3 G/A), and rs2227981 (PD-1.5 C/T), and susceptibility to RA.